Credentialing Service forDSCSA Compliance

Spherity’s compact app to authenticate direct and indirect Authorized Trading Partners in real-time

CARO app user interface with verifiable credentials

CARO's Ecosystem

Minimize the complexity of regulatory requirements now

Don't get caught out by the 2023 deadline!
Solve the challenge of DSCSA Authorized Trading Partner (ATP) authentication. Run automated verifications with ease.

DSCSA 2023 deadline is approaching

Easily plug into your existing processes

Go through a one-time onboarding process. Start directly without technical integration.

“Using the Spherity Credentialing Service in combination with SAP’s VRS, we have an electronic mechanism in place to verify each trading partner. There was no technical integration required to get started. All I had to do was to sign up with Spherity and tell my VRS that I want to use credentialing. I encourage all trading partners under DSCSA to add credentialing to their roadmap for 2023.”

Dave Mason Novartis Compliance Lead
Dave Mason, Supply Chain Compliance and Serialization Lead, Novartis
CARO app user interface with VRS transaction flow

Trading Partners in the pharmaceutical supply chain

Who is affected by the U.S. Drug Supply Chain Security Act (DSCSA)?

Manufacturer

Accepts or transfers direct product ownership. Must have valid registration.

Wholesale Distributor

Accepts or transfers direct product ownership. Must hold valid license.

Dispenser

Accepts or transfers direct product ownership. Must hold valid license.

Repackager

Accepts or transfers direct product ownership. Must have valid registration.

Third-Party Logistics Provider

Accepts or transfers direct product possession. Must hold valid license.

DSCSA Challenge

CARO is helping you close the compliance gap

The DSCSA requires new enhancements to pharmaceutical supply chain security by fall 2023.

Having instant assurance that you only interact with trusted and authorized trading partners is a huge challenge.

Challenge accepted

Using CARO you can:

  • be sure that the counterparty is who they say they are;
  • facilitate automated mutual Authorized Trading Partners checks in direct and indirect interactions;
  • interact with counterparties using other OCI-conformant service providers;
  • rely on secure messaging.

When using VRS initially, we utilized GLNs to identify a trading partner. We discovered GLNs that were not active or not associated with the requesting entity. GLNs also do not inform about authorized status. Additionally, we had no proof that the provided GLN actually came from the trading partner. This was a compliance gap we had to close.

Dave Mason, Supply Chain Compliance and Serialization Lead at Novartis

Dave Mason

Supply Chain Compliance and Serialization Lead, Novartis

Supporting you on your road to compliance

Solve the challenge of ATP authentication today and continue on your road to full DSCSA compliance by fall 2023.

Request a free trial